NIH Begins Testing Mixed COVID-19 Vaccine Schedules
The U.S. National Institutes of Health (NIH) has announced that it has begun an early stage Phase 1/2 clinical trial to examining what happens when an adult who is fully vaccinated with one type of COVID-19 vaccine, is given a different booster vaccine from another manufacturer three to four months later.1 Currently, there are three […]
